Isoprinosine Ewopharma 50 mg ml sirop 50 mg/ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

isoprinosine ewopharma 50 mg ml sirop 50 mg/ml

ewopharma international s.r.o - inosinum pranobex - sirop - 50 mg/ml

Isoprinosine Ewopharma 500 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

isoprinosine ewopharma 500 mg comprimate

ewopharma international s.r.o - inosinum pranobex - comprimate - 500 mg

Visine picaturi oftalmice, solutie 0,05% Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

visine picaturi oftalmice, solutie 0,05%

johnson & johnson srl - tetryzolini hydrochloridum - picaturi oftalmice, solutie - 0,05%

VISINE CLASSIC 0,5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

visine classic 0,5 mg/ml

mcneil products limited c/o johnson & johnson - tetryzolinum - picaturi oft., sol. - 0,5mg/ml - decongestionante si antialergice simpatomimetice utilizate ca decongestionante

Visine 0,5 mg/ml picături oftalmice, soluţie Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

visine 0,5 mg/ml picături oftalmice, soluţie

johnson & johnson srl - tetryzolini hydrochloridum - picături oftalmice, soluţie - 0,5 mg/ml

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

LEVO-METHASAN 5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levo-methasan 5 mg/ml

g.l. pharma gmbh - austria - levomethadonum - conc. pt. sol. orala - 5mg/ml - med. pentru tratamentul dependentei de substante medicamente utilizate in tratamentul dependentei de opioide

Veregen 100 mg g 100 mg/g unguent Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

veregen 100 mg g 100 mg/g unguent

meditrina pharmaceuticals ltd - extractum camellia sinensis (l.) o. kuntze, folium - unguent - 100 mg/g

Sinerdol ISO capsule 300 mg + 150 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sinerdol iso capsule 300 mg + 150 mg

antibiotice sa, sc - capsule - 300 mg + 150 mg

BLEOMICINA ACCORD 15000UI România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bleomicina accord 15000ui

accord healthcare limited - marea britanie - bleomycinum sulfas - pulb. pt. sol. inj./perf. - 15000ui - antibiotice citotoxice si substante inrudite alte antibiotice citotoxice